Ironwood Pharmaceuticals, Inc. (IRWD)
3.515
-0.10
(-2.90%)
USD |
NASDAQ |
Oct 30, 13:38
Ironwood Pharmaceuticals Cash and Short Term Investments (Annual) : 215.46M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 215.46M |
| December 31, 2024 | 88.56M |
| December 31, 2023 | 92.15M |
| December 31, 2022 | 657.45M |
| December 31, 2021 | 621.38M |
| December 31, 2020 | 364.30M |
| December 31, 2019 | 178.27M |
| December 31, 2018 | 174.42M |
| December 31, 2017 | 221.42M |
| December 31, 2016 | 305.22M |
| Date | Value |
|---|---|
| December 31, 2015 | 439.39M |
| December 31, 2014 | 248.33M |
| December 31, 2013 | 197.60M |
| December 31, 2012 | 168.23M |
| December 31, 2011 | 164.02M |
| December 31, 2010 | 250.86M |
| December 31, 2009 | 123.14M |
| December 31, 2008 | 253.68M |
| December 31, 2007 | 91.94M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| AbbVie, Inc. | 5.257B |
| Xencor, Inc. | 547.73M |
| Viking Therapeutics, Inc. | 705.74M |
| IDEAYA Biosciences, Inc. | 639.39M |
| BioMarin Pharmaceutical, Inc. | 1.561B |